Lanreotide in the management of small bowel angioectasias: seven-year data from a tertiary centre

Scandinavian Journal of Gastroenterology
S Chetcuti ZammitReena Sidhu

Abstract

Haemorrhage from small bowel angioectasias (SBAs) can be debilitating to patients who are very often elderly and have multiple comorbidities. Our aim was to assess the use of lanreotide in addition to endotherapy in patients with SBAs. Patients with SBAs on capsule endoscopy (CE) who received lanreotide injections from January 2010 to till the present day at the Royal Hallamshire Hospital in Sheffield were included. Baseline demographics were recorded. Efficacy was evaluated in terms of improvement in mean haemoglobin, transfusion requirements and bleeding episodes. Twelve patients (67% males, mean age 74 SD ± 15.5 years) were included. All patients had multiple comorbidities. Lanreotide was given at a dosage of 60 mg (42%), 90 mg (33%) or 120 mg (25%). It was given at a four-week interval in 75% of patients and at a six-week interval in 17% of patients. One patient (8%) received a single dose. The mean duration of treatment was 19 months SD ± 14.5. Only 17% of patients had their lanreotide stopped due to cholelithiasis. There was a significant improvement in mean haemoglobin: 86.8 versus 98.0 (131-166 g/L, p = .012). The mean number of bleeding episodes (4.18 versus 1.09, p = .010) and packed red cells (323 versus 152, p = .00...Continue Reading

References

Dec 1, 1992·American Journal of Hematology·W D CheyP L Bockenstedt
Sep 1, 1992·Journal of Clinical Gastroenterology·B S LewisJ D Waye
Jul 1, 1990·Gastrointestinal Endoscopy·P G FoutchR A Sanowski
Sep 23, 1982·The New England Journal of Medicine·W A Gracie, D F Ransohoff
Oct 1, 1993·The Journal of Surgical Research·R BarrieW S Fletcher
Jul 1, 1994·American Journal of Hematology·T Lavabre-BertrandC Rouanet
Jan 25, 1996·The New England Journal of Medicine·S W LambertsL J Hofland
Jan 1, 1996·Baillière's Clinical Endocrinology and Metabolism·L J Hofland, S W Lamberts
Dec 29, 1998·Scandinavian Journal of Gastroenterology. Supplement·Z Tulassay
Apr 14, 1999·The American Journal of Gastroenterology·F JunqueraJ R Malagelada
Apr 14, 1999·The American Journal of Gastroenterology·A K KubbaK R Palmer
Nov 24, 1999·The New England Journal of Medicine·S SinghalB Barlogie
Jan 7, 2000·The American Journal of Pathology·H SauerM Wartenberg
May 9, 2000·Biochemical Pharmacology·T D StephensB J Fillmore
Mar 21, 2002·Nature Reviews. Cancer·Adrian L Harris
Dec 31, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fairooz KabbinavarEmily Bergsland
May 17, 2003·Clinical Therapeutics·S James Matthews, Christopher McCoy
May 1, 2004·Gastroenterología y hepatología·V Munítiz RuizP Parrilla Paricio
Jan 13, 2005·Artificial Organs·Tsuneo TakenakaHiromichi Suzuki
Feb 22, 2007·The American Journal of Gastroenterology·Félix JunqueraJuan-Ramón Malagelada
Sep 5, 2007·Alimentary Pharmacology & Therapeutics·G ScaglioneI Sorrentini
Nov 23, 2007·The New England Journal of Medicine·Meletios DimopoulosUNKNOWN Multiple Myeloma (010) Study Investigators
Dec 21, 2007·Leukemia·A PalumboUNKNOWN International Myeloma Working Group
Dec 25, 2007·Gastrointestinal Endoscopy·Tomonori YanoKentaro Sugano
Jun 27, 2008·The New England Journal of Medicine·Steven M Strasberg
Jun 11, 2009·European Journal of Gastroenterology & Hepatology·Esteve SaperasJuan R Malagelada
Oct 10, 2009·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·Majid AlmadiAndrew Szilagyi
Mar 17, 2010·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Maria Elena RiccioniGuido Costamagna
Dec 15, 2010·Digestive Diseases and Sciences·Anthony T DeBenedetLaurel R Fisher

❮ Previous
Next ❯

Citations

Mar 10, 2018·Current Opinion in Gastroenterology·Stefania Chetcuti Zammit, Reena Sidhu
Jun 27, 2019·World Journal of Gastroenterology : WJG·Eiji SakaiNobuyuki Matsuhashi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of the South Carolina Medical Association
G L PortwoodP B Cotton
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
David R Cave
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
Patarapong KamalapornNorman Marcon
© 2022 Meta ULC. All rights reserved